| Income Statement |
| Operating Expenses | 5.85M |
|
| Research and Development Expense | 3.48M |
| Selling, General and Administrative Expense | 2.37M |
| Operating Income | -5.85M |
| Interest Expense | 23.00 |
| Net Income | -5.45M |
| Net Income Common Stock | -5.45M |
| Net Income Common Stock (USD) | -5.45M |
| Consolidated Income | -5.45M |
| Earnings per Basic Share | -0.09 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.09 |
| Earning Before Interest & Taxes (EBIT) | -5.45M |
| Earning Before Interest & Taxes (USD) | -5.45M |
| Weighted Average Shares | 60.32M |
| Weighted Average Shares Diluted | 60.32M |
| Balance Sheet |
| Cash and Equivalents | 45.09M |
| Cash and Equivalents (USD) | 45.09M |
| Current Assets | 47.38M |
| Property, Plant & Equipment Net | 161.65K |
| Total Assets | 47.54M |
| Debt Current | 143.45K |
| Total Debt | 143.45K |
| Current Liabilities | 9.66M |
| Total Liabilities | 9.66M |
| Accumulated Retained Earnings (Deficit) | -492.86M |
| Shareholders Equity | 37.89M |
| Shareholders Equity (USD) | 37.89M |
| Assets Non-Current | 161.65K |
| Total Debt (USD) | 143.45K |
| Deferred Revenue | 6.00M |
| Trade and Non-Trade Payables | 137.48K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 70.71K |
| Net Cash Flow from Financing | -15.30M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.91M |
| Capital Expenditure | -23.10K |
| Issuance (Repayment) of Debt Securities | -15.30M |
| Net Cash Flow from Investing | -23.10K |
| Net Cash Flow from Operations | -4.59M |
| Share Based Compensation | 1.64M |